SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-115592
Filing Date
2024-10-18
Accepted
2024-10-18 16:02:49
Documents
11
Period of Report
2024-10-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K atha-20241016.htm   iXBRL 8-K 50138
  Complete submission text file 0000950170-24-115592.txt   170888

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20241016.xsd EX-101.SCH 26991
13 EXTRACTED XBRL INSTANCE DOCUMENT atha-20241016_htm.xml XML 4888
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 241380749
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)